DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
6.03
0.02 (0.33%)
At close: Aug 15, 2025, 3:59 PM
6.03
0.08%
After-hours: Aug 15, 2025, 04:10 PM EDT
DiaMedica Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.7M | -7.71M | -7.9M | -6.27M | -5.12M | -5.15M | -5.16M | -4.47M | -4.48M | -5.27M | -3.75M | -3.06M | -3.36M | -3.51M | -3.25M | -3.45M | -3.27M | -3.62M |
Depreciation & Amortization | -177K | 11K | 11K | 10K | 10K | 8K | 8K | 8K | 7K | 7K | 6K | 7K | 6K | 6K | 6K | 6K | 6K | 6K |
Stock-Based Compensation | 771K | 867K | 589K | 565K | 443K | 488K | 456K | 425K | 380K | 422K | 411K | 418K | 365K | 308K | 298K | 303K | 446K | 511K |
Other Working Capital | n/a | -629K | 1.35M | 1.06M | 396K | -1.45M | 1.23M | -360K | 194K | -1.05M | 772K | 59K | 244K | -715K | 203K | -393K | 1.16M | -838K |
Other Non-Cash Items | -493K | -241K | -311K | -346K | -300K | -311K | 345.97K | 18K | 17K | -188K | -112K | -26K | 56K | 135K | 15K | 15K | 14K | 14K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -466.72K | -424K | -227K | n/a | n/a | n/a | n/a | n/a | 110K | 13K | 12K | 26K |
Change in Working Capital | n/a | -79K | 1.18M | 1.57M | 447K | -1.69M | 1.24M | -353K | -730K | -58K | 680K | 299K | 435K | -829K | 13K | 67K | 707K | -1.25M |
Operating Cash Flow | -7.6M | -7.15M | -6.43M | -4.47M | -4.52M | -6.65M | -3.58M | -4.8M | -5.03M | -5.09M | -2.77M | -2.36M | -2.5M | -3.89M | -2.8M | -3.05M | -2.09M | -4.31M |
Capital Expenditures | -6K | -12K | -7K | -9K | 68.38 | -9K | -2.69K | -10K | -4K | -7K | -32K | -43K | -6K | n/a | -7K | -2K | -4K | -9K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -24.4K | -1.21K | 28.12K | -2.52K | -4.76K | -2.12K | -2.53K | n/a | -1.98 | -39.98 | 31.06 | 2K |
Purchase of Investments | -9.5M | -6.87M | -10.79M | -21.58M | -8.26M | -9.78M | -3.97M | -11.79M | -42.92M | -9.82M | -9.79M | -8.38M | -14.13M | -13.38M | -22.07M | -22.5M | -13.32M | -11.92M |
Sales Maturities Of Investments | 18.47M | 13.5M | 16M | 16M | 13M | 14M | 10.37M | 13M | 14.79M | 12.34M | 14.54M | 10.5M | 16.66M | 15.59M | 13.39M | 9.67M | 14.31M | 11.92M |
Other Investing Acitivies | n/a | n/a | -439 | n/a | n/a | n/a | 24.4K | 1.21K | -28.12K | 2.52K | 4.76K | 2.12K | 2.53K | 2.21K | -8.68K | -12.83K | 993.00 | 2K |
Investing Cash Flow | 8.96M | 6.62M | 5.21M | -5.58M | 4.74M | 4.21M | 6.39M | 1.2M | -28.13M | 2.51M | 4.72M | 2.07M | 2.53M | 2.21M | -8.69M | -12.83M | 989K | -9K |
Debt Repayment | n/a | -3K | -3K | -3K | -2K | -1K | -924 | -2K | -2K | -1K | -842.12 | -1.92K | -1.99K | -1K | n/a | -2K | n/a | -2K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | 205M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 161K | n/a | 198.18K | -36.89K | 83.18K | n/a | n/a | n/a | 36.85M | n/a | -157.88 | -76.46 | -12.09 | n/a | -1K | n/a | -1K | 244K |
Financial Cash Flow | 161K | 91K | 120K | 123K | 11.75M | -1K | -489.34K | -6K | 36.85M | -1K | -1K | -2K | -2K | -1K | -19 | 29.86K | n/a | 242.00 |
Net Cash Flow | 1.52M | -436K | -1.11M | -9.93M | 11.97M | -2.45M | 2.31M | -3.61M | 3.69M | -2.58M | 1.96M | -291K | 30K | -1.68M | -11.51M | 13.99M | -1.1M | -4.08M |
Free Cash Flow | -7.6M | -7.16M | -6.44M | -4.48M | -4.52M | -6.66M | -3.58M | -4.81M | -5.03M | -5.1M | -2.8M | -2.4M | -2.5M | -3.89M | -2.81M | -3.05M | -2.09M | -4.32M |